产品详情
Targets
Target | Value |
---|---|
VEGFR1/FLT1 | IC50: 0.1nM |
VEGFR2/Flk1 | IC50: 0.18nM |
VEGFR2/KDR | IC50: 0.2nM |
VEGFR3 | IC50: 0.1nM-0.3nM |
PDGFRβ | IC50: 1.6nM |
Kit | IC50: 1.7nM |
PDGFRα | IC50: 5.0nM |
CSF-1R | IC50: 73nM |
FLT3 | IC50: >1μM |
In vitro | DMSO | Warmed: 30 mg/mL (77.62 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 25.87 mL | 129.37 mL | 258.73 mL |
0.5 mM | 5.17 mL | 25.87 mL | 51.75 mL |
1 mM | 2.59 mL | 12.94 mL | 25.87 mL |
5 mM | 0.52 mL | 2.59 mL | 5.17 mL |
*The above data is based on the productmolecular weight 386.5 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A10103 |
---|---|
作用机制 | Inhibitor (抑制剂) |
M. Wt | 386.5 |
Formula | C22H18N4OS |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. |
CAS No. | 319460-85-0 |
Synonyms | AG 013736 |
SMILES | CNC(=O)C1=CC=CC=C1SC2=CC3=C(C=C2)C(=NN3)/C=C/C4=CC=CC=N4 |
产品标签
Product Questions
Product Questions
Tivozanib (AV-951)
Tivozanib (AV-951)是一种口服VEGF受体酪氨酸激酶抑制剂,旨在抑制所有三种VEGF受体。
CYC116 (CYC-116)
CYC116 (CYC-116)是一种有效的Aurora A/B抑制剂,Ki为8.0 nM/9.2 nM,对VEGFR2(Ki为44 nM)作用稍弱。
Linifanib (ABT-869)
Linifanib (ABT-869)是一种结构新颖的有效RTK,VEGF和PDGF抑制剂,对人内皮细胞,PDGFR-β,KDR和CSF-1R的IC50分别为0.…
ZM 323881 hydrochloride
ZM 323881 hydrochloride是一种有效且选择性的人血管内皮生长因子受体2(VEGFR2/KDR)激酶活性抑制剂。
BMS-817378
BMS-817378是Met/VEGFR-2双重抑制剂BMS-794833的新型前药。
Cediranib (AZD2171)
Cediranib (AZD2171)是一种高效的VEGFR(KDR)抑制剂,此外对c-Kit和PDGFRβ也具有相似的抑制活性,对VEGFR的选择性比P…
Motesanib Diphosphate (AMG-706)
Motesanib也称为AMG-706,是一种有效的ATP竞争性的VEGFR1/2/3抑制剂,IC50分别为2 nM/3 nM/6 nM;对Kit具有相似的抑制…